Karen Bergman | VP, IR & Corporate Communications |
Thomas Neff | Founder, Chairman & CEO |
Peony Yu | Chief Medical Officer |
Christine Chung | VP China Operations |
Elias Kouchakji | VP, Clinical Development, Drug Safety & Pharmacovigilance |
Pat Cotroneo | CFO |
Joel Beatty | Citigroup |
Michael Yee | Jefferies |
Geoffrey Porges | Leerink Partners |
Andrew Tsai | William Blair |
Difei Yang | Mizuho Securities |
Welcome to FibroGen Incorporated Second Quarter 2018 Financial Results Conference Call. My name is Gerald, and I will be your operator for today's call. [Operator Instructions].
For opening remarks and introduction I will now turn the call over to Karen Bergman, Vice President, Investor Relations and Corporate Communications. Karen, you may begin.